POXIDE-20 DT Clinical Monograph & Batch COA
Certified DCGI Formulation Literature (PDF)
POXIDE-20 DT
Piroxicam 20mg DT
POXIDE-20 DT (Piroxicam 20mg DT) is manufactured under strict WHO-GMP compliance for maximum bioavailability and therapeutic efficacy.
Clinical Pharmacology & Therapeutic Profile
Comprehensive therapeutic guidelines for medical practitioners and institutional procurement
Therapeutic Indications
Mechanism of Action (MOA)
The active pharmacological principles in POXIDE-20 DT deliver targeted therapeutic action through standardized systemic bioavailability and verified pharmacodynamics.
As directed by the registered medical practitioner. Strictly adhere to full course duration.
Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.
Store below 25°C in a dry place. Protect from moisture and direct sunlight.
WHO-GMP Certified Purity
Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.
Alu-Alu Moisture Barrier
Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.
Exclusive District Monopoly
Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.
Technical Product Specifications
Active Medical Composition
POXIDE-20 DT features Piroxicam 20mg DT prepared to high pharmaceutical purity standards.
*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.
Customer & Clinical Reviews
Real feedback from registered physicians, stockists, PCD franchise partners, and verified buyers.
Based on 1 verified review
Supplied reliably to private nursin for POXIDE-20 DT
POXIDE-20 DT has been supplied reliably to private nursing homes and clinics in our district, demonstrating excellent bioavailability and consistent therapeutic efficacy in clinical practice. Clear monograph labeling and legible dosage instructions make patient guidance straightforward. Distributor billing and dispatch turnaround times are prompt, with strong repeat demand from clinics.
Questions Regarding POXIDE-20 DT
What is the therapeutic indication and composition of POXIDE-20 DT?
POXIDE-20 DT contains Piroxicam 20mg DT indicated for Indicated for therapeutic management within specified clinical indications under qualified physician guidance. as formulated by Sygnus Biotech.
What packaging presentations are available for POXIDE-20 DT?
POXIDE-20 DT is supplied in tamper-evident 10 x 10 Alu-Alu / Blister Pack, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.
Is monopoly PCD franchise territory available for POXIDE-20 DT?
Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for POXIDE-20 DT along with promotional visual aids, product cards, and marketing support.
What is the regulatory schedule and minimum order quantity (MOQ)?
POXIDE-20 DT is categorized as Schedule H with an introductory PCD franchise MOQ of 100 units per batch.
Related Formulations in Tablet
View all Tablet →
DAIBET-G2 V
Glimepiride 2mg + Metformin Hydrochloride 500mg + Voglibose 0.2mg Bilayered
